Journal
JOURNAL OF CYSTIC FIBROSIS
Volume 20, Issue 5, Pages 881-890Publisher
ELSEVIER
DOI: 10.1016/j.jcf.2021.05.006
Keywords
Cystic Fibrosis-Related Diabetes; Cystic Fibrosis; Vasoactive Intestinal Peptide; Pancreas; Insulin; Glucagon
Categories
Funding
- Cystic Fibrosis Canada
- Cystic Fibrosis Foundation (USA)
- Dalhousie Faculty of Medicine Research Excellence award
- CFF grant
Ask authors/readers for more resources
Investigation revealed decreased VIP levels and reduced innervation in the pancreas of CF mice, leading to decreased insulin secretion, increased glucagon production, and elevated random blood glucose levels. Therefore, VIP deficiency may contribute to the development of CFRD.
Vasoactive intestinal peptide (VIP), a 28-amino acid neuropeptide with potent anti-inflammatory, bronchodilatory and immunomodulatory functions, is secreted by intrinsic neurons innervating all exocrine glands, including the pancreas, in which it exerts a regulatory function in the secretion of insulin and glucagon. Cystic fibrosis-related diabetes (CFRD) is the most common co-morbidity associated with cystic fibrosis (CF), impacting approximately 50% of adult patients. We recently demonstrated a 50% reduction of VIP abundance in the lungs, duodenum and sweat glands of C57Bl/6 CF mice homozygous for the F508del-CFTR disease-causing mutation. VIP deficiency resulted from a reduction in VIPergic and cholinergic innervation, starting before signs of CF disease were observed. As VIP functions as a neuromodulator with insulinotropic effect on pancreatic beta cells, we sought to study changes in VIP in the pancreas of CF mice. Our goal was to examine VIP content and VIPergic innervation in the pancreas of 8- and 17-week-old F508del-CFTR homozygous mice and to determine whether changes in VIP levels would contribute to CFRD development. Our data showed that a decreased amount of VIP and reduced innervation are found in CF mice pancreas, and that these mice also exhibited reduced insulin secretion, up-regulation of glucagon production and high random blood glucose levels compared to same-age wild-type mice. We propose that low level of VIP, due to reduced innervation of the CF pancreas and starting at an early disease stage, contributes to changes in insulin and glucagon secretion that can lead to CFRD development. (C) 2021 The Authors. Published by Elsevier B.V. on behalf of European Cystic Fibrosis Society.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available